Technetium (99mTc) arcitumomab

Technetium (99mTc) Arcitumomab

Technetium (99mTc) arcitumomab

to get instant updates about 'Technetium (99mTc) Arcitumomab' on your MyPage. Meet other similar minded people. Its Free!

X 

All Updates


Description:
Technetium (<sup>99m</sup>Tc) arcitumomab is a drug used for the diagnostic imaging of colorectal cancers, marketed by Immunomedics. It consists of the Fab' fragment of a monoclonal antibody (arcitumomab, trade name CEA-Scan) and a radionuclide, technetium-99m.

Chemistry

Technetium (<sup>99m</sup>Tc) arcitumomab is an immunoconjugate. Arcitumomab is a Fab' fragment of IMMU-4, a murine IgG1 monoclonal antibody extracted from the ascites of mice. The enzyme pepsin cleaves the F(ab')<sub>2</sub> fragment off the antibody. From this, the Fab' fragment is prepared by mild reduction.

Before application, arcitumomab is reconstituted with a solution of the radioactive agent sodium pertechnetate (<sup>99m</sup>Tc) from a technetium generator.

Mechanism of action

Arcitumomab recognizes carcinoembryonic antigen (CEA), an antigen over-expressed in 95% of colorectal cancers. Consequently, the antibody accumulates in such tumours together with the radioisotope, which emits photons. Via single photon emission computed tomography (SPECT), high-resolution images showing localisation, remission or progression, and metastases of the tumour can be obtained.

Contraindications

Technetium (<sup>99m</sup>Tc) arcitumomab is contraindicated for patients with known allergies or...
Read More

No feeds found

All
Posting your question. Please wait!...


No updates available.
No messages found
Suggested Pages
Tell your friends >
about this page
 Create a new Page
for companies, colleges, celebrities or anything you like.Get updates on MyPage.
Create a new Page
 Find your friends
  Find friends on MyPage from